Joseph Truitt, Chief Executive Officer at ACHILLION PHARMACEUTICALS INC (ACHN), sold 266,968 shares at $6.37 ($1.7M) on 2019-10-16, disclosed to the SEC on 2019-10-18.
Open-market sale of $1.7M ACHN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.37 | 33,250 | $212K | 12.5% |
| 2 | $6.37 | 33,250 | $212K | 12.5% |
| 3 | $6.37 | 100,234 | $638K | 37.5% |
| 4 | $6.37 | 100,234 | $638K | 37.5% |
| Total | $6.37 avg | 266,968 | $1.7M | 100% |
| Filing → |
| ACHN | SELL | 2014-08-26 | $271K | — | Filing → |
| ACHN | SELL | 2014-06-17 | $196K | — | Filing → |
| ACHN | SELL | 2014-06-11 | $301K | — | Filing → |